There is a great deal of hype surrounding the concept of personalized medicine.
Personalized medicine is rooted in the belief that since individuals possess nuanced and …

With healthcare becoming digital, patients today are more empowered than ever before. As
a result, digital health solutions have become the need of the hour to keep up with an …

Health care is evolving and with it the need to reform medical education. As the practice of
medicine enters the age of artificial intelligence (AI), the use of data to improve clinical …

Rare diseases represent a highly heterogeneous group of disorders with high phenotypic
and genotypic diversity within individual conditions. Due to the small numbers of people …

Digital therapeutics are emerging as a new form of therapeutic interventions. Unlike
conventional therapeutics, digital therapeutics deliver interventions directly to patients using …

Abstract Coronavirus disease 2019 (COVID-19) has accelerated the growth of the digital
therapeutics (DTx) market; therefore, development strategies for new DTx products are …

In the near future, Artificial Intelligence (AI) is expected to participate more and more in
decision making processes, in contexts ranging from healthcare to politics. For example, in …

The promise of transforming digital technologies into treatments is what drives the
development of digital therapeutics (DTx), generally known as software applications …

There is an urgent need to improve the clinical management of major depressive disorder
(MDD), which has become increasingly prevalent over the past two decades. Several gaps …

The field of regulatory affairs deals with the regulatory requirements for marketing
authorization of therapeutic products. This field is facing a myriad of forces impacting all …